04:36am OpenAI agents attacked RubyGems before Hugging Face incident, researchers say RE
04:09am OpenAI agents attacked software service RubyGems before Hugging Face incident, WSJ reports RE
12/09 Carlyle Group Insider Sold Shares Worth $17,096,000, According to a Recent SEC Filing MT
12/09 AstraZeneca Says Late-Stage Etcamah Breast-Cancer Trial Misses Main Goal MT
12/09 Seagate Technology Holdings Insider Sold Shares Worth $2,456,436, According to a Recent SEC Filing MT
12/09 Seagate Technology Holdings Insider Sold Shares Worth $1,162,156, According to a Recent SEC Filing MT
12/09 Seagate Technology Holdings Insider Sold Shares Worth $493,355, According to a Recent SEC Filing MT
12/09 Seagate Technology Holdings Insider Sold Shares Worth $570,240, According to a Recent SEC Filing MT
12/09 United Therapeutics Insider Sold Shares Worth $4,772,295, According to a Recent SEC Filing MT
12/09 AstraZeneca's breast cancer pill fails in late-stage trial RE
12/09 United States Lime & Minerals Insider Sold Shares Worth $2,200,000, According to a Recent SEC Filing MT
12/09 Meta Muse Personal AI Agent Promising, But Near-Term Monetization Potential Likely Limited, Wedbush Says MT
12/09 US Commerce Department finalizes steep duties on solar imports from India, Indonesia, Laos RE
12/09 Adobe Q3 Results Show AI Resilience but Limited Upside, UBS Says MT
12/09 Top Midday Decliners MT
12/09 OpenAI's Altman May Slow Down AI Development MT
11/09 Descartes Systems Shares Rise After Fiscal Q2 Beat MT
11/09 Qualys Shares Fall After Wedbush Downgrade MT
11/09 Microsoft Plans to More Than Triple Data Center Capacity MT
11/09 Meta Muse Monetization Seen Limited Near Term, Wedbush Says MT
11/09 Tesla eyes European freight market with long-delayed Semi truck RE
11/09 SPS Commerce in Talks to Be Acquired by GTCR MT
11/09 Tesla's Semi Truck Slated for Deliveries in Europe From 2027 MT
11/09 Consumer Sentiment Falls as Year-Ahead Inflation Outlook Hits Highest Since June MT
11/09 Rothschild & Co Redburn Adjusts Marvell Technology Price Target to $239.77 From $211.97, Maintains Neutral Rating MT
11/09 Wedbush Adjusts Price Target on Meta Platforms to $650 From $595, Keeps Neutral Rating MT
11/09 Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy MT
11/09 Jazz Pharmaceuticals Sees Meaningful Long-Term Value From Ziihera's Pursuits Beyond GEA, UBS Says MT
11/09 Vicor to Acquire New Hampshire Properties for New Manufacturing Facilities MT
11/09 Meta Reportedly Held Meetings with European Investors for Potential Bond Sale MT
11/09 Descartes Q2 Tops Expectations as Acquisitions, AI Investments Support Growth, RBC Says MT
11/09 Wedbush Adjusts Price Target on Meta Platforms to $650 From $595, Keeps Neutral Rating MT
11/09 Adobe's AI, Freemium Products Key to Annual Recurring Revenue Growth, RBC Says MT
11/09 August Consumer Inflation Hits Three-Month High as Core CPI Unexpectedly Accelerates MT
11/09 Meta Speaking With European Bond Investors MT
11/09 Meta Speaking With European Bond Investors, Bloomberg Reports MT
11/09 Wsfs Financial Insider Sold Shares Worth $258,007, According to a Recent SEC Filing MT
11/09 Goldman Sachs Adjusts Steel Dynamics Price Target to $301 From $300, Maintains Buy Rating MT
11/09 UBS Adjusts Price Target on Wynn Resorts to $138 From $145, Keeps Buy Rating MT
11/09 UBS Adjusts Jazz Pharmaceuticals PT to $337 From $315, Maintains Buy Rating MT
No results match your criteria
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!